Gene expression levels of both CDC42 and ACTR2 were notably elevated in breast cancer tissues compared to their expression in normal tissues, and were ranked among the highest in terms of expression across various cancer types (Figure S4). This evidence concerns the gene CDC42 and breast carcinoma.